APA
Gordon J., Danne T., Beresford-Hulme L., Bennet H., Tank A., Edmonds C., Thorén F., Scheerer M. F. & McEwan P. (2020). Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme. : Diabetes therapy : research, treatment and education of diabetes and related disorders.
Chicago
Gordon Jason, Danne Thomas, Beresford-Hulme Lee, Bennet Hayley, Tank Amarjeet, Edmonds Christopher, Thorén Fredrik, Scheerer Markus Florian and McEwan Phil. 2020. Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme. : Diabetes therapy : research, treatment and education of diabetes and related disorders.
Harvard
Gordon J., Danne T., Beresford-Hulme L., Bennet H., Tank A., Edmonds C., Thorén F., Scheerer M. F. and McEwan P. (2020). Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme. : Diabetes therapy : research, treatment and education of diabetes and related disorders.
MLA
Gordon Jason, Danne Thomas, Beresford-Hulme Lee, Bennet Hayley, Tank Amarjeet, Edmonds Christopher, Thorén Fredrik, Scheerer Markus Florian and McEwan Phil. Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme. : Diabetes therapy : research, treatment and education of diabetes and related disorders. 2020.